The stock of Hill-Rom Holdings (NYSE:HRC, 30-year Financials) is estimated to be fairly valued, according to GuruFocus Value calculation. GuruFocus Value is GuruFocus' estimate of the fair value at which the stock should be traded. It is calculated based on the historical multiples that the stock has traded at, the past business growth and analyst estimates of future business performance. If the price of a stock is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher. At its current price of $110.67 per share and the market cap of $7.4 billion, Hill-Rom Holdings stock shows every sign of being fairly valued. GF Value for Hill-Rom Holdings is shown in the chart below.
Because Hill-Rom Holdings is fairly valued, the long-term return of its stock is likely to be close to the rate of its business growth, which averaged 1.6% over the past three years and is estimated to grow 2.41% annually over the next three to five years.
Link: These companies may deliever higher future returns at reduced risk.
It is always important to check the financial strength of a company before buying its stock. Investing in companies with poor financial strength have a higher risk of permanent loss. Looking at the cash-to-debt ratio and interest coverage is a great way to understand the financial strength of a company. Hill-Rom Holdings has a cash-to-debt ratio of 0.16, which is in the bottom 10% of the companies in the industry of Medical Devices & Instruments. The overall financial strength of Hill-Rom Holdings is 5 out of 10, which indicates that the financial strength of Hill-Rom Holdings is fair. This is the debt and cash of Hill-Rom Holdings over the past years:
Companies that have been consistently profitable over the long term offer less risk for investors who may want to purchase shares. Higher profit margins usually dictate a better investment compared to a company with lower profit margins. Hill-Rom Holdings has been profitable 10 over the past 10 years. Over the past twelve months, the company had a revenue of $3 billion and earnings of $4.21 a share. Its operating margin is 15.37%, which ranks better than 74% of the companies in the industry of Medical Devices & Instruments. Overall, the profitability of Hill-Rom Holdings is ranked 7 out of 10, which indicates fair profitability. This is the revenue and net income of Hill-Rom Holdings over the past years:
Growth is probably the most important factor in the valuation of a company. GuruFocus research has found that growth is closely correlated with the long term performance of a company's stock. The faster a company is growing, the more likely it is to be creating value for shareholders, especially if the growth is profitable. The 3-year average annual revenue growth rate of Hill-Rom Holdings is 1.6%, which ranks in the middle range of the companies in the industry of Medical Devices & Instruments. The 3-year average EBITDA growth rate is 3.3%, which ranks in the middle range of the companies in the industry of Medical Devices & Instruments.
Another way to evaluate a company's profitability is to compare its return on invested capital (ROIC) to its weighted cost of capital (WACC). Return on invested capital (ROIC) measures how well a company generates cash flow relative to the capital it has invested in its business. The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. If the ROIC is higher than the WACC, it indicates that the company is creating value for shareholders. Over the past 12 months, Hill-Rom Holdings's ROIC was 9.08, while its WACC came in at 4.52. The historical ROIC vs WACC comparison of Hill-Rom Holdings is shown below:
In summary, Hill-Rom Holdings (NYSE:HRC, 30-year Financials) stock appears to be fairly valued. The company's financial condition is fair and its profitability is fair. Its growth ranks in the middle range of the companies in the industry of Medical Devices & Instruments. To learn more about Hill-Rom Holdings stock, you can check out its 30-year Financials here.
To find out the high quality companies that may deliever above average returns, please check out GuruFocus High Quality Low Capex Screener.
